Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
17.92
+0.19 (1.07%)
Apr 30, 2026, 2:55 PM CST
SHA:688670 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 67.75 | 84.19 | 83.42 | 70.44 | 174.73 | 36.69 |
Short-Term Investments | - | - | 153.55 | 361.95 | - | - |
Trading Asset Securities | 81.01 | 109.05 | 195.39 | 175.42 | 390.57 | 657.31 |
Cash & Short-Term Investments | 148.77 | 193.25 | 432.37 | 607.82 | 565.3 | 694 |
Cash Growth | -35.95% | -55.31% | -28.87% | 7.52% | -18.55% | 442.13% |
Accounts Receivable | 116.91 | 139.74 | 112.96 | 81.24 | 341.11 | 342.76 |
Other Receivables | 0.46 | 0.48 | 0.5 | 0.48 | 0.54 | 0.89 |
Receivables | 117.37 | 140.22 | 113.45 | 81.71 | 341.65 | 343.65 |
Inventory | 32.58 | 16.33 | 34.93 | 21.98 | 31.95 | 27.98 |
Other Current Assets | 8.92 | 5.86 | 1.83 | 10.74 | 12.11 | 4.08 |
Total Current Assets | 307.64 | 355.66 | 582.58 | 722.24 | 951.02 | 1,070 |
Property, Plant & Equipment | 809.89 | 813.3 | 809.46 | 794.95 | 785.9 | 523.89 |
Long-Term Investments | 83.15 | 92.87 | - | - | - | - |
Other Intangible Assets | 28.8 | 30.1 | 30.22 | 35.32 | 40.41 | 45.46 |
Long-Term Deferred Tax Assets | 74.5 | 74.5 | 55.81 | 33.31 | 17.75 | 21.79 |
Long-Term Deferred Charges | 51.93 | 52.14 | 51.36 | 42.42 | 27.81 | 15.46 |
Other Long-Term Assets | 0.04 | 0.05 | 3.48 | 3.36 | 3.89 | 78.19 |
Total Assets | 1,356 | 1,419 | 1,533 | 1,632 | 1,827 | 1,754 |
Accounts Payable | 54.3 | 77.9 | 25.06 | 11.48 | 9.66 | 7.52 |
Accrued Expenses | 5.57 | 10.02 | 62.7 | 62.87 | 144.52 | 132.36 |
Short-Term Debt | 70.05 | 68.05 | 47.63 | 64.06 | 42.04 | 10.01 |
Current Portion of Long-Term Debt | 2 | 2 | - | - | - | - |
Current Income Taxes Payable | 0.72 | 1.12 | - | - | - | - |
Current Unearned Revenue | - | - | - | - | 0.05 | 0.05 |
Other Current Liabilities | 69.37 | 82.57 | 75.49 | 88.93 | 106.23 | 71.73 |
Total Current Liabilities | 202.02 | 241.66 | 210.88 | 227.34 | 302.5 | 221.68 |
Long-Term Debt | 28.02 | 28.01 | - | - | - | - |
Long-Term Unearned Revenue | 24.86 | 25.12 | 25.11 | 25.56 | 25.98 | 25.67 |
Long-Term Deferred Tax Liabilities | 0.03 | 0.03 | 0.09 | 0.06 | 0.09 | 0.35 |
Other Long-Term Liabilities | 24.29 | 24.68 | 19.25 | 7.56 | 38.54 | 45.42 |
Total Liabilities | 279.22 | 319.5 | 255.33 | 260.52 | 367.11 | 293.12 |
Common Stock | 123.2 | 123.2 | 123.2 | 123.2 | 88 | 88 |
Additional Paid-In Capital | 1,116 | 1,116 | 1,116 | 1,116 | 1,151 | 1,151 |
Retained Earnings | -162.67 | -140.29 | 38.18 | 131.68 | 220.27 | 222.73 |
Shareholders' Equity | 1,077 | 1,099 | 1,278 | 1,371 | 1,460 | 1,461 |
Total Liabilities & Equity | 1,356 | 1,419 | 1,533 | 1,632 | 1,827 | 1,754 |
Total Debt | 100.07 | 98.05 | 47.63 | 64.06 | 42.04 | 10.01 |
Net Cash (Debt) | 48.7 | 95.19 | 384.74 | 543.76 | 523.26 | 683.99 |
Net Cash Growth | -73.48% | -75.26% | -29.24% | 3.92% | -23.50% | - |
Net Cash Per Share | 0.40 | 0.77 | 3.13 | 4.44 | 4.28 | 6.52 |
Filing Date Shares Outstanding | 124.37 | 123.2 | 123.2 | 123.2 | 123.2 | 123.2 |
Total Common Shares Outstanding | 124.37 | 123.2 | 123.2 | 123.2 | 123.2 | 123.2 |
Working Capital | 105.62 | 114 | 371.7 | 494.91 | 648.52 | 848.02 |
Book Value Per Share | 8.66 | 8.92 | 10.37 | 11.13 | 11.85 | 11.86 |
Tangible Book Value | 1,048 | 1,069 | 1,247 | 1,336 | 1,419 | 1,416 |
Tangible Book Value Per Share | 8.43 | 8.68 | 10.12 | 10.84 | 11.52 | 11.49 |
Buildings | - | - | 117.03 | 107.68 | 107.22 | 107.18 |
Machinery | - | - | 221.67 | 206.49 | 204.15 | 196.33 |
Construction In Progress | - | - | 661.51 | 649.46 | 619.86 | 341.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.